Avo (Decision/Risk Analysis) Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
50
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$10M
- Investors
-
24
Avo (Decision/Risk Analysis) General Information
Description
Operator of a no-code artificial intelligence platform intended to automate clinical workflows across care settings. The company's platform connects to leading electronic health records and supports configurable workflows across specialties for tasks such as pre-charting, care planning, utilization management, and ordering, with role-based support for physicians, advanced practice providers, nurses, dietitians, and trainees, enabling provider organizations to reduce documentation effort, improve workflow consistency, and increase clinician time available for patient care.
Contact Information
Website
www.avomd.comCorporate Office
- 405 Lexington Avenue
- 9th Floor
- New York, NY 10174
- United States
Corporate Office
- 405 Lexington Avenue
- 9th Floor
- New York, NY 10174
- United States
Avo (Decision/Risk Analysis) Timeline
Avo (Decision/Risk Analysis) Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Later Stage VC (Series A) | 31-Mar-2026 | $10M | Completed | Generating Revenue | ||
| 8. Seed Round | 23-Jun-2023 | Completed | Generating Revenue | |||
| 7. Accelerator/Incubator | 05-Oct-2022 | Completed | Generating Revenue | |||
| 6. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 5. Accelerator/Incubator | 08-Jun-2021 | Completed | Generating Revenue | |||
| 4. Seed Round | 01-May-2021 | Completed | Generating Revenue | |||
| 3. Grant | 30-Apr-2020 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | 06-Dec-2019 | Completed | Generating Revenue | |||
| 1. Accelerator/Incubator | 21-Dec-2018 | Completed | Generating Revenue |
Avo (Decision/Risk Analysis) Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-2 | ||||||||
| Series A-1 | ||||||||
| Seed-6 | ||||||||
| Seed-5 | ||||||||
| Seed-4 | ||||||||
| Seed-3 | ||||||||
| Seed-2 | 3,951 | $0.000100 | $5.06 | $5.06 | 1x | $5.06 | 0.87% | |
| Seed-1 | 85,558 | $0.000100 | $54.93 | $54.93 | 1x | $54.93 | 11.99% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Avo (Decision/Risk Analysis) Comparisons
Industry
Financing
Details
Avo (Decision/Risk Analysis) Competitors (3)
One of Avo (Decision/Risk Analysis)’s 3 competitors is AgileMD, a Venture Capital-Backed company based in San Francisco, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| AgileMD | Venture Capital-Backed | San Francisco, CA | ||||
| MDCalc | Venture Capital-Backed | New York, NY | ||||
| Etiometry | Venture Capital-Backed | Dedham, MA |
Avo (Decision/Risk Analysis) Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Avo (Decision/Risk Analysis) Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Avo (Decision/Risk Analysis) Investors (24)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Noro-Moseley Partners | Growth/Expansion | Minority | ||
| Scrub Capital | Venture Capital | Minority | ||
| 500 Startups LatAm | Accelerator/Incubator | Minority | ||
| Digital Health Venture Partners | Venture Capital | Minority | ||
| Epsilon Health. | Venture Capital | Minority |
Avo (Decision/Risk Analysis) FAQs
-
When was Avo (Decision/Risk Analysis) founded?
Avo (Decision/Risk Analysis) was founded in 2018.
-
Where is Avo (Decision/Risk Analysis) headquartered?
Avo (Decision/Risk Analysis) is headquartered in New York, NY.
-
What is the size of Avo (Decision/Risk Analysis)?
Avo (Decision/Risk Analysis) has 50 total employees.
-
What industry is Avo (Decision/Risk Analysis) in?
Avo (Decision/Risk Analysis)’s primary industry is Decision/Risk Analysis.
-
Is Avo (Decision/Risk Analysis) a private or public company?
Avo (Decision/Risk Analysis) is a Private company.
-
What is the current valuation of Avo (Decision/Risk Analysis)?
The current valuation of Avo (Decision/Risk Analysis) is .
-
What is Avo (Decision/Risk Analysis)’s current revenue?
The current revenue for Avo (Decision/Risk Analysis) is .
-
How much funding has Avo (Decision/Risk Analysis) raised over time?
Avo (Decision/Risk Analysis) has raised $18M.
-
Who are Avo (Decision/Risk Analysis)’s investors?
Noro-Moseley Partners, Scrub Capital, 500 Startups LatAm, Digital Health Venture Partners, and Epsilon Health. are 5 of 24 investors who have invested in Avo (Decision/Risk Analysis).
-
Who are Avo (Decision/Risk Analysis)’s competitors?
AgileMD, MDCalc, and Etiometry are competitors of Avo (Decision/Risk Analysis).
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
